Paolo Tombesi - 09 Feb 2022 Form 4 Insider Report for Turning Point Therapeutics, Inc.

Role
EVP & Chief Financial Officer
Signature
/s/ Paolo Tombesi
Issuer symbol
N/A
Transactions as of
09 Feb 2022
Net transactions value
$0
Form type
4
Filing time
11 Feb 2022, 17:11:13 UTC
Previous filing
27 Jul 2021
Next filing
29 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TPTX Common Stock Award $0 +16,283 +120% $0.000000 29,883 09 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPTX Stock Option (right to buy) Award $0 +58,600 $0.000000 58,600 09 Feb 2022 Common Stock 58,600 $37.68 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock unit award granted under the Issuer's 2019 Equity Plan.
F2 1/48th of the shares vest monthly following February 9, 2022.